395 related articles for article (PubMed ID: 14599784)
1. Vaccinology of classical swine fever: from lab to field.
van Oirschot JT
Vet Microbiol; 2003 Nov; 96(4):367-84. PubMed ID: 14599784
[TBL] [Abstract][Full Text] [Related]
2. The double-antigen ELISA concept for early detection of E
Meyer D; Fritsche S; Luo Y; Engemann C; Blome S; Beyerbach M; Chang CY; Qiu HJ; Becher P; Postel A
Transbound Emerg Dis; 2017 Dec; 64(6):2013-2022. PubMed ID: 28158921
[TBL] [Abstract][Full Text] [Related]
3. The challenges of classical swine fever control: modified live and E2 subunit vaccines.
Huang YL; Deng MC; Wang FI; Huang CC; Chang CY
Virus Res; 2014 Jan; 179():1-11. PubMed ID: 24211665
[TBL] [Abstract][Full Text] [Related]
4. Plant-made E2 glycoprotein single-dose vaccine protects pigs against classical swine fever.
Laughlin RC; Madera R; Peres Y; Berquist BR; Wang L; Buist S; Burakova Y; Palle S; Chung CJ; Rasmussen MV; Martel E; Brake DA; Neilan JG; Lawhon SD; Adams LG; Shi J; Marcel S
Plant Biotechnol J; 2019 Feb; 17(2):410-420. PubMed ID: 29993179
[TBL] [Abstract][Full Text] [Related]
5. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.
Aebischer A; Müller M; Hofmann MA
Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189
[TBL] [Abstract][Full Text] [Related]
6. Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review.
de Smit AJ
Vet Q; 2000 Oct; 22(4):182-8. PubMed ID: 11087126
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of the Erns protein of classical swine fever virus in yeast and its application in an indirect enzyme-linked immunosorbent assay for antibody differentiation of infected from vaccinated animals.
Luo Y; Li L; Austermann-Busch S; Dong M; Xu J; Shao L; Lei J; Li N; He WR; Zhao B; Li S; Li Y; Liu L; Becher P; Sun Y; Qiu HJ
J Virol Methods; 2015 Sep; 222():22-7. PubMed ID: 26005003
[TBL] [Abstract][Full Text] [Related]
8. DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif.
von Rosen T; Rangelova D; Nielsen J; Rasmussen TB; Uttenthal Å
Vet Microbiol; 2014 Jun; 170(3-4):224-31. PubMed ID: 24629779
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of maternally derived antibodies upon intramuscular vaccination against classical swine fever with Suvaxyn
Schröder C; Dräger C; Aebischer A; Dähnert L; Breidenstein C; Mamerow S; Leidenberger S; Beer M; Blome S
Vet Microbiol; 2016 Nov; 196():14-17. PubMed ID: 27939149
[TBL] [Abstract][Full Text] [Related]
10. Classical swine fever vaccines-State-of-the-art.
Blome S; Moß C; Reimann I; König P; Beer M
Vet Microbiol; 2017 Jul; 206():10-20. PubMed ID: 28069290
[TBL] [Abstract][Full Text] [Related]
11. Classical swine fever: comparison of oronasal immunisation with CP7E2alf marker and C-strain vaccines in domestic pigs.
Tignon M; Kulcsár G; Haegeman A; Barna T; Fábián K; Lévai R; Van der Stede Y; Farsang A; Vrancken R; Belák K; Koenen F
Vet Microbiol; 2010 Apr; 142(1-2):59-68. PubMed ID: 19857935
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain.
Xia SL; Xiang GT; Lei JL; Du M; Wang Y; Zhou M; Liu Y; Ji S; Wang YL; Luo Y; Sun Y; Qiu HJ
Vet Microbiol; 2016 Nov; 196():50-54. PubMed ID: 27939155
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of a Classical swine fever virus C-strain deletion mutant and ability to differentiate infected from vaccinated animals.
Kortekaas J; Ketelaar J; Vloet RP; Loeffen WL
Vet Microbiol; 2011 Jan; 147(1-2):11-8. PubMed ID: 20541334
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics.
Eblé PL; Geurts Y; Quak S; Moonen-Leusen HW; Blome S; Hofmann MA; Koenen F; Beer M; Loeffen WLA
Vet Microbiol; 2013 Mar; 162(2-4):437-446. PubMed ID: 23238022
[TBL] [Abstract][Full Text] [Related]
15. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
[TBL] [Abstract][Full Text] [Related]
16. Reduced specificity of E
Meyer D; Loeffen W; Postel A; Fritsche S; Becher P
Transbound Emerg Dis; 2018 Apr; 65(2):e505-e508. PubMed ID: 29314759
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
Blome S; Gabriel C; Schmeiser S; Meyer D; Meindl-Böhmer A; Koenen F; Beer M
Vet Microbiol; 2014 Feb; 169(1-2):8-17. PubMed ID: 24411658
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
[TBL] [Abstract][Full Text] [Related]
19. Development of a classical swine fever subunit marker vaccine and companion diagnostic test.
Moormann RJ; Bouma A; Kramps JA; Terpstra C; De Smit HJ
Vet Microbiol; 2000 Apr; 73(2-3):209-19. PubMed ID: 10785329
[TBL] [Abstract][Full Text] [Related]
20. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.
Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C
Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
